questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Anticorps antifongiques
Anticorps antifongiques : Questions médicales fréquentes
Diagnostic
5
Infections fongiques
Diagnostic médical
Anticorps
Tests sérologiques
Symptômes
Infections fongiques
Cultures fongiques
Infections fongiques
Imagerie médicale
Infections fongiques
Symptômes
5
Symptômes
Infections fongiques
Douleur
Infections fongiques
Infections fongiques
Symptômes cutanés
Infections fongiques
Variabilité des symptômes
Infections fongiques
Asymptomatique
Prévention
5
Prévention
Infections fongiques
Immunodépression
Prévention des infections
Vaccins
Infections fongiques
Nutrition
Prévention des infections
Vêtements
Infections fongiques
Traitements
5
Antifongiques
Traitement des infections
Antifongiques
Mécanisme d'action
Infections fongiques
Traitement spécifique
Effets secondaires
Antifongiques
Complications
5
Complications
Infections fongiques
Infections fongiques
Mortalité
Gestion des complications
Antifongiques
Infections fongiques
Variabilité des complications
Allergies
Infections fongiques
Facteurs de risque
5
Facteurs de risque
Infections fongiques
Mode de vie
Prévention des infections
Voyages
Infections fongiques
Antécédents médicaux
Infections fongiques
Conditions environnementales
Infections fongiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anticorps antifongiques : Questions médicales les plus fréquentes",
"headline": "Anticorps antifongiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anticorps antifongiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anticorps antifongiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anticorps",
"url": "https://questionsmedicales.fr/mesh/D000906",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps",
"code": {
"@type": "MedicalCode",
"code": "D000906",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antifongiques",
"alternateName": "Antibodies, Fungal",
"code": {
"@type": "MedicalCode",
"code": "D000908",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrew Adamatzky",
"url": "https://questionsmedicales.fr/author/Andrew%20Adamatzky",
"affiliation": {
"@type": "Organization",
"name": "Unconventional Computing Laboratory, UWE, Bristol, UK. Electronic address: andrew.adamatzky@uwe.ac.uk."
}
},
{
"@type": "Person",
"name": "Antoni Gandia",
"url": "https://questionsmedicales.fr/author/Antoni%20Gandia",
"affiliation": {
"@type": "Organization",
"name": "Institute for Plant Molecular and Cell Biology, CSIC-UPV, Valencia, Spain."
}
},
{
"@type": "Person",
"name": "Arturo Casadevall",
"url": "https://questionsmedicales.fr/author/Arturo%20Casadevall",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, Maryland 21205, United States."
}
},
{
"@type": "Person",
"name": "Itai Doron",
"url": "https://questionsmedicales.fr/author/Itai%20Doron",
"affiliation": {
"@type": "Organization",
"name": "Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Xin V Li",
"url": "https://questionsmedicales.fr/author/Xin%20V%20Li",
"affiliation": {
"@type": "Organization",
"name": "Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Evaluation of commercial immunodiffusion reagents for detecting serum anti-Paracoccidioides antibodies.",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38808801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0037-8682-0094-2024"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis.",
"datePublished": "2022-09-19",
"url": "https://questionsmedicales.fr/article/36121238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.02573-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37689265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2023.08.032"
}
},
{
"@type": "ScholarlyArticle",
"name": "The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36773771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2023.02.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease.",
"datePublished": "2022-08-22",
"url": "https://questionsmedicales.fr/article/35989383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10620-022-07630-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
},
{
"@type": "ListItem",
"position": 8,
"name": "Anticorps antifongiques",
"item": "https://questionsmedicales.fr/mesh/D000908"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anticorps antifongiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anticorps antifongiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anticorps antifongiques",
"description": "Comment diagnostiquer une infection fongique ?\nQuels tests détectent les anticorps antifongiques ?\nLes symptômes aident-ils au diagnostic ?\nQuelle est l'importance des cultures fongiques ?\nLes tests d'imagerie sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anticorps antifongiques",
"description": "Quels sont les symptômes d'une infection fongique ?\nLes infections fongiques causent-elles des douleurs ?\nY a-t-il des symptômes spécifiques aux champignons ?\nLes symptômes varient-ils selon le champignon ?\nLes infections fongiques peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anticorps antifongiques",
"description": "Comment prévenir les infections fongiques ?\nLes personnes à risque doivent-elles prendre des précautions ?\nLes vaccins protègent-ils contre les infections fongiques ?\nL'alimentation influence-t-elle la prévention ?\nLes vêtements peuvent-ils prévenir les infections fongiques ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anticorps antifongiques",
"description": "Quels traitements sont disponibles pour les infections fongiques ?\nLes anticorps antifongiques sont-ils utilisés en thérapie ?\nComment les antifongiques agissent-ils ?\nLes traitements sont-ils différents pour chaque champignon ?\nY a-t-il des effets secondaires aux antifongiques ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anticorps antifongiques",
"description": "Quelles complications peuvent survenir avec une infection fongique ?\nLes infections fongiques peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le champignon ?\nLes infections fongiques peuvent-elles causer des allergies ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anticorps antifongiques",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque d'infection fongique ?\nLes voyages augmentent-ils le risque d'infections fongiques ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000908#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection fongique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, cultures et examens microscopiques."
}
},
{
"@type": "Question",
"name": "Quels tests détectent les anticorps antifongiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques spécifiques peuvent détecter les anticorps antifongiques dans le sang."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic et les tests nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des cultures fongiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cultures fongiques permettent d'identifier le type de champignon responsable de l'infection."
}
},
{
"@type": "Question",
"name": "Les tests d'imagerie sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests d'imagerie peuvent aider à évaluer l'étendue de l'infection fongique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection fongique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections fongiques causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir, notamment dans les zones infectées ou enflammées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux champignons ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains champignons provoquent des symptômes spécifiques, comme des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le champignon ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de champignon et la localisation de l'infection."
}
},
{
"@type": "Question",
"name": "Les infections fongiques peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections fongiques peuvent être asymptomatiques, surtout chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections fongiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, éviter les environnements humides et renforcer le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées doivent éviter les contacts avec des sources fongiques."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre les infections fongiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins efficaces contre la plupart des infections fongiques."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut renforcer le système immunitaire et aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les vêtements peuvent-ils prévenir les infections fongiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements en tissus respirants peut réduire le risque d'infections cutanées fongiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections fongiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antifongiques oraux, topiques ou intraveineux selon la gravité."
}
},
{
"@type": "Question",
"name": "Les anticorps antifongiques sont-ils utilisés en thérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les anticorps antifongiques ne sont pas utilisés comme traitement, mais comme indicateurs."
}
},
{
"@type": "Question",
"name": "Comment les antifongiques agissent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques ciblent les membranes cellulaires des champignons ou inhibent leur croissance."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour chaque champignon ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choix du traitement dépend du type de champignon et de la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux antifongiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antifongiques peuvent provoquer des effets secondaires comme des nausées ou des éruptions."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection fongique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques, des lésions organiques et des septicémies."
}
},
{
"@type": "Question",
"name": "Les infections fongiques peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections fongiques, surtout chez les immunodéprimés, peuvent être mortelles."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le champignon ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications dépendent du type de champignon et de l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Les infections fongiques peuvent-elles causer des allergies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections fongiques peuvent déclencher des réactions allergiques chez certains individus."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, le diabète, l'utilisation d'antibiotiques et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection fongique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise hygiène augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infections fongiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où les infections fongiques sont courantes peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou d'hospitalisations augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements humides et chauds favorisent la prolifération des champignons et augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Unconventional Computing Laboratory, UWE, Bristol, UK. Electronic address: andrew.adamatzky@uwe.ac.uk.
Publications dans "Anticorps antifongiques" :
3 publications dans cette catégorie
Affiliations :
Institute for Plant Molecular and Cell Biology, CSIC-UPV, Valencia, Spain.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, Maryland 21205, United States.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA. iliev@med.cornell.edu.
The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA. iliev@med.cornell.edu.
Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. iliev@med.cornell.edu.
Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA. iliev@med.cornell.edu.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Unité Biologie des ARN des Pathogènes Fongiques, Département de Mycologie, Institut Pasteur, Paris, 75015, France. janbon@pasteur.fr.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Groupe à 5 ans Immunologie des Infections Fongiques, Département de Mycologie, Institut Pasteur, Paris, 75015, France.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Unité de Mycologie Moléculaire, Département de Mycologie, Institut Pasteur, UMR2000, Paris, 75015, France.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Unité Biologie et Pathogénicité Fongiques, Département de Mycologie, Institut Pasteur, USC2019 INRA, Paris, 75015, France.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Unconventional Computing Laboratory, UWE, Bristol, UK; Center for Bioinspired Soft Robotics, Istituto Italiano di Tecnologia, Via Morego 30, 10163 Genova, Italy.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: heitm001@duke.edu.
Publications dans "Anticorps antifongiques" :
2 publications dans cette catégorie
Publications dans "Anticorps antifongiques" :
Accurate diagnosis of paracoccidioidomycosis is crucial for improving patient outcomes. Paracoccidioides antibody detection by double immunodiffusion (DID) is a convenient diagnostic tool, but testing...
We assessed DID performance using a commercially prepared Paracoccidioides reagents (IMMY, USA), involving 40 serum specimens, including 20 from patients with proven paracoccidioidomycosis and 20 from...
Our findings suggest that DID using commercial reagents may provide a feasible tool with satisfactory testing performance for anti-Paracoccidioides antibody detection....
Coccidioidomycosis, also called valley fever (VF), is a fungal infection with endemicity in desert regions of the western United States as well as certain arid regions of Central and South America. La...
To evaluate the performance of Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis (CPA) by using a cohort of patients with histologically proven CPA as a reference stan...
We collected Aspergillus-specific IgG antibody titres from patients with histologically proven CPA in collaboration with CPAnet study sites in Denmark, Germany, Belgium, India, Moldova, and Pakistan (...
Using patients with histologically proven CPA as the reference standard, the ImmunoCAP® Aspergillus-specific IgG antibody test had a sensitivity and specificity of 85.1% (95% CI: 71.7-93.8%) and 83.6%...
Our study results confirm a high sensitivity of the Aspergillus-specific IgG antibody test for the diagnosis of CPA when using patients with histologically proven CPA as a reference standard. However,...
Aspergillus-specific IgG antibody (Asp IgG) has been successfully applied in the diagnosis of chronic pulmonary aspergillosis. We explored its value in nonneutropenic invasive pulmonary aspergillosis ...
We enrolled 372 clinically suspected nonneutropenic patients with IPA from February 2015 to August 2022. After excluding 4 cases with Aspergillus colonization, the remaining 368 cases were finally con...
At cut-off value of ≥80 AU/mL, Asp IgG had much higher sensitivity (59.6% vs. 19.2%, p < 0.0001), but lower specificity (77.0% vs. 96.3%, p < 0.0001) than serum galactomannan (GM) (cut-off value of ≥1...
The diagnostic value of Asp IgG for IPA is superior to serum GM, and a little inferior to BALF GM in nonneutropenic patients with IPA. Considering the convenience of taking blood samples, it is a good...
The pathogenic processes in the preclinical phase of inflammatory bowel disease (IBD) are mainly unknown....
To study typical antibodies for IBD in the preclinical phase in a cohort of Northern Sweden....
Antibodies typical for IBD (ASCA, pANCA, lactoferrin-ANCA, antibodies to goblet cells, and pancreas antigen) were analyzed in 123 subjects with preclinical ulcerative colitis (UC), 54 subjects with pr...
The mean years between blood samples and IBD diagnosis were for UC 5.1 (SD 3.5) years and CD 5.6 (SD 3.5) years. There was no difference in the proportion of overall positive antibodies between subjec...
We found no significant increase in antibodies typical for IBD years before diagnosis except for ASCA, which was slightly more common in subjects who later developed CD. Very few subjects had detectab...
Chronic pulmonary aspergillosis (CPA) is common among individuals with underlying lung diseases. The clinical manifestations of CPA include systemic symptoms (e.g., weight loss, fatigue, fever), chron...
Histoplasma capsulatum exposure is rarely suspected in Indonesia. Pulmonary histoplasmosis can occur simultaneously with pulmonary tuberculosis (TB) or as an alternative diagnosis in clinically-diagno...
This was a sub-study of 306 participants from a prospective cohort pulmonary TB study conducted at seven TB referral hospitals in Indonesia. The study population was presumptive pulmonary TB adult pat...
12.7% (39/306) of pulmonary TB patients were positive for anti-H. capsulatum IgG antibodies (DR-TB patients (15.9%, 18/114), DS-TB (13.0%, 15/115), and clinically-diagnosed TB (7.8%, 6/77)). The media...
Our results provide evidence of exposure to H. capsulatum among pulmonary TB patients in Indonesia. Further studies are needed to provide a comprehensive picture of this fungal disease in other popula...
Cryptococcosis predominantly presents as a meningoencephalitis in Thailand. Early and expeditious diagnosis is essential for reducing both mortality and morbidity associated with cryptococcal meningit...
We have developed the large-scale prototype for the rapid detection of cryptococcal polysaccharide antigens by utilizing a single antibody sandwich ICT format employing MAb 18B7, which is highly speci...
The diagnostic sensitivity, specificity, and accuracy for the in-house MAb 18B7 ICT were 99.10%, 97.61%, and 97.83%, respectively. The agreement kappa (κ) coefficient was 0.968 based on the retrospect...
The data suggest that this in-house MAb 18B7 ICT will be highly beneficial for addressing the issue of cryptococcal infection in Thailand. Moreover, it is anticipated that this inexpensive ICT can pla...
The finding that some mAbs are antifungal suggests that antibody immunity may play a key role in the defense of the host against mycotic infections. The discovery of antibodies that guard against fung...
Coccidioidomycosis is a fungal disease associated with soil exposure that frequently goes undiagnosed due at least in part to its nonspecific presentation and the lack of clinical suspicion by health ...